{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-071617","form_type":"8-K","ticker":"PEPG","cik":"0001835597","company_name":"PepGen Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.592760+00:00","generated_at":"2026-06-01T05:07:16.236274+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"PepGen promotes Michelle Mellion to CMO, Hayley Parker to SVP Global Regulatory Affairs","bullets":["Michelle Mellion, M.D., promoted to Chief Medical Officer effective immediately.","Hayley Parker, Ph.D., promoted to Senior Vice President, Global Regulatory Affairs effective immediately.","Mellion joined PepGen as SVP Head of Clinical Development; previously held roles at Fulcrum Therapeutics.","Parker joined PepGen as VP Regulatory Affairs; previously led regulatory strategy at Scholar Rock.","CEO McArthur cites their leadership in driving clinical and regulatory strategies for rare muscle disorders."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-071617","json":"https://secwatch.observer/filing/0000950170-24-071617.json","markdown":"https://secwatch.observer/filing/0000950170-24-071617.md","text":"https://secwatch.observer/filing/0000950170-24-071617.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835597/000095017024071617/0000950170-24-071617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835597/000095017024071617/pepg-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:07:16.236274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}